FDA approves Amgen biosimilar of AbbVie’s Humira
The Food and Drug Administration approved Amgen’s Humira biosimilar Sept. 23. Amjevita, formerly known as ABP 501 and made by Thousand Oaks-biotech giant Amgen, replicates the effects of Humira, which is approved to treat nine conditions including rheumatoid arthritis, skin disorders and colon inflammation. Humira, made by Chicago-based competitor AbbVie, typically costs $20,000 per year Read More →
Brown signs bill to streamline CEQA process
Gov. Jerry Brown signed a bill that aims to expedite and add more transparency to environmental reviews. Sen. Hannah-Beth Jackson, D-Santa Barbara, authored Senate Bill 122 along with Sen. Jerry Hill, D-San Mateo, which strives to streamline the California Environmental Quality Act process. CEQA requires state and local agencies to identify significant environmental impacts of Read More →
Limoneira declares dividend of 5 cents per common share
Limoneira declared a dividend of 5 cents per common share for stockholders of record as of Oct. 3. The board of directors for the Santa Paula agribusiness and real estate development company announced Sept. 21 that it would pay the dividend Oct. 17. As of 12:34 p.m. Sept. 23, Limoneira stock was up 0.7 percent Read More →
Redeveloped Miramar resort in Montecito to open in summer 2018
The long-awaited redevelopment of the Miramar resort in Montecito will likely come to fruition in summer 2018, Caruso Affiliated announced on Sept. 23. Hong Kong-based luxury resort operator Rosewood Hotels & Resorts will run the Rosewood Miramar Beach Montecito resort at 1555 S. Jameson Lane. The tentative plan is to start site grading in November, Read More →
Central Coast tourism-generated tax revenue up
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Iconic Wagon Wheel rolling along as $450M development
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
